HEALTHCARE SERVICES CEPTON strategies, a Management Consulting firm for Healthcare Industries
A GROWING DEMAND IN A CONSTRAINED ENVIRONMENT
IMPROVING BOTH PRODUCTIVITY AND QUALITY AT THE SAME TIME
Our consultancy offer is tailored to both private firms and not-for-profit organisations in the healthcare services sector.
In an environment where demand grows faster than the available resources, companies face huge productivity challenges. The market is in a rapid consolidation phase, with competition rising and R&D demand increasing. Preserving strong service and expertise is a must.
Discover our other fields of intervention:
With technological developments, the homecare market continues to grow. However there is also pressure to reduce the length of stays.
Operators installing medical equipment and infrastructure in homes are facing growing demands but decreasing reimbursement rates year on year. Such trends have triggered consolidation: the industry is currently in an active M&A phase.
CEPTON assists these players in defining growth strategies and identifies ways to improve operational efficiency and reduce costs. Recent projects have involved infusion, nutrition, respiratory assistance, chemotherapy, and diabetes.
Private clinics face more pressure with regards to fixed reimbursement rates.
Private Healthcare facilities must therefore optimise their processes to become more cost-efficient without sacrificing the quality of their services.
CEPTON identifies solutions to mitigate these challenges and works on the key success factors for sustainability. For example, streamlining healthcare processes and identifying areas where unnecessary tests and procedures can be reduced, and helping develop the reputation and attractiveness of the facilities for prospectus patients.
The diversification of expertise combined with the complexity of projects and scientific progress has led companies to evolve their R&D strategies. There is a greater requirement for a wider range of skills, which has led researchers to work in partnerships with major universities, private research institutes and start-ups in biotechnology.
Our teams are assisting various pharmaceutical companies, diagnostic firms, and both public and private research institutes to develop effective partnerships and governance processes, as well as helping redesign their R&D strategies, and access financing.
Contract development and production.
A developing, globalizing market:
CDMOs (Contract development and Manufacturing Organisations) are traditionally partners of start-ups that do not possess the internal ability to develop their molecules. However, they are becoming increasingly attractive to larger companies who outsource various activities of production and development.
Our consulting firm helps design growth strategies to such players, including in optimising their plan to attract private equity funds.
«A growing demand for quality in a difficult economic context.»
Our work on care facilities also comprises:
New and innovative technologies are rife in research laboratories and can play an active role in the world of research, from next generation sequencing and protein or oligonucleotide synthesis, to new analytical tools and bioproduction processes.
Many service businesses using such technologies have been created to serve the research segment and become acquisition targets of bigger firms and investment funds.
CEPTON assesses the growth potential of these start-ups and performs due diligence.
Healthcare "Big Data"
CEPTON carefully monitors new algorithms and technologies to understand the potential impact on clinical research strategies of its clients. This helps us assess which clinically relevant information can be obtained from the ever-growing flow of healthcare data generated by the myriad of clinical trials that take place each year.